Kolon Life Science Inc banner
K

Kolon Life Science Inc
KOSDAQ:102940

Watchlist Manager
Kolon Life Science Inc
KOSDAQ:102940
Watchlist
Price: 61 000 KRW -2.4% Market Closed
Market Cap: ₩796.7B

Kolon Life Science Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kolon Life Science Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
K
Kolon Life Science Inc
KOSDAQ:102940
Research & Development
-₩14.1B
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
-7%
Yuhan Corp
KRX:000100
Research & Development
-₩197B
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
-19%
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-₩162.2B
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-₩189.1B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
-1%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-₩8.7B
CAGR 3-Years
-8%
CAGR 5-Years
17%
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
Research & Development
-₩5.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

Kolon Life Science Inc
Glance View

Market Cap
796.7B KRW
Industry
Pharmaceuticals

KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. The company is headquartered in Seoul, Seoul and currently employs 451 full-time employees. The company went IPO on 2009-04-07. The firm operates its business under two segments. The Chemical Business segment produces and sells raw drug products, which are the raw materials of new drugs and generic drugs, antibacterial agents that suppress bacterial growth, water treatment agents for environmental purification, and functional material products for cosmetics. The Bio Business segment manufactures and sells bio new medicines based on cell gene therapy products.

Intrinsic Value
26 521.45 KRW
Overvaluation 57%
Intrinsic Value
Price
K

See Also

What is Kolon Life Science Inc's Research & Development?
Research & Development
-14.1B KRW

Based on the financial report for Sep 30, 2025, Kolon Life Science Inc's Research & Development amounts to -14.1B KRW.

What is Kolon Life Science Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-7%

Over the last year, the Research & Development growth was 14%. The average annual Research & Development growth rates for Kolon Life Science Inc have been 2% over the past three years , and -7% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett